References of Breast Awareness Article Caitriona Plunkett

Anastasi, N. and Lusher, J. (2017) ‘The impact of breast cancer awareness interventions on breast screening uptake among women in the United Kingdom: A systematic review.’ Journal of Health Psychology, 24(1) pp. 113-124.

Breast Cancer Care (2020) Know your breasts. A guide to breast awareness and screening. Breast Cancer Now. [Online] [Accessed on 10th October 2020] https://breastcancernow.org/information-support/publication/know-your-breasts-guide-breast-awareness-screening-bcc2

Carrieri, D., Farrimond, H., Kelly, S. and Turnpenny, P. (2016) ‘Families dealing with the uncertainty of genetic disorders: the case of Neurofibromatosis Type 1.’ Sociology of Health & Illness, 38(5) pp. 753-767.

Da Silva, A. V., Rodrigues, F. R., Pureza, M., Lopes, V. G. S. and Cunha, K. S. (2015) ‘Breast cancer and neurofibromatosis type 1: A diagnostic challenge in patients with a high number of neurofibromas.’ BMC Cancer, 15(1) p. 183.

Dischinger, P. S., Tovar, E. A., Essenburg, C. J., Madaj, Z. B., Gardner, E. E., Callaghan, M. E., Turner, A. N., Challa, A. K., et al. (2018) ‘NF1 deficiency correlates with estrogen receptor signaling and diminished survival in breast cancer.’ NPJ Breast Cancer, 4(1) pp. 29-14.

Evans, D. G. (2012) ‘Are we ready for targeted early breast cancer detection strategies in women with NF1 aged 30–49 years?’ American Journal of Medical Genetics. Part A, 158A(12) pp. 3054-3055.

Evans, D. G. R., Kallionpaa, R. A., Clementi, M., Trevisson, E., Mautner, V. F., Howell, S. J., Lewis, L., Zehou, O., et al. (2020) ‘Breast cancer in neurofibromatosis 1: survival and risk of contralateral breast cancer in a five country cohort study.’ Genetics in Medicine, 22(2) pp. 398-406.

Hirbe, A. C. and Gutmann, D. H. (2014) ‘Neurofibromatosis type 1: a multidisciplinary approach to care.’ Lancet Neurology, 13(8) pp. 834-843.

Kennedy, C. (2018) ‘Interventions for raising breast cancer awareness in women.’ International Journal of Nursing Practice, 24(3) pp. e12582.

Maani, N., Westergard, S., Yang, J., Scaranelo, A. M., Telesca, S., Thain, E., Schachter, N. F., McCuaig, J. M., et al. (2019) ‘NF1 Patients Receiving Breast Cancer Screening: Insights from The Ontario High Risk Breast Screening Program.’ Cancers, 11(5) p. 707.

National Health Service (2018) How should I check my breasts? NHS. [Online] [Accessed 10th October 2020] https://www.nhs.uk/common-health-questions/womens-health/how-should-i-check-my-breasts/

Suarez-Kelly, L. P., Yu, L., Kline, D., Schneider, E. B., Agnese, D. M. and Carson, W. E. (2019) ‘Increased breast cancer risk in women with neurofibromatosis type 1: a meta-analysis and systematic review of the literature.’ Hereditary Cancer in Clinical Practice, 17(1) pp. 12-13.

Uusitalo, E., Rantanen, M., Kallionpää, R. A., Pöyhönen, M., Leppävirta, J., Ylä-Outinen, H., Riccardi, V. M., Pukkala, E., et al. (2016) ‘Distinctive Cancer Associations in Patients With Neurofibromatosis Type 1.’ Journal of Clinical Oncology, 34(17) p. 1978.

Uusitalo, E., Kallionpää, R. A., Kurki, S., Rantanen, M., Pitkäniemi, J., Kronqvist, P., Härkönen, P., Huovinen, R., et al. (2017) ‘Breast cancer in neurofibromatosis type 1: Overrepresentation of unfavourable prognostic factors.’ British Journal of Cancer, 116(2) pp. 211-217.

Walker, L., Thompson, D., Easton, D., Ponder, B., Ponder, M., Frayling, I. and Baralle, D. (2006) ‘A prospective study of neurofibromatosis type 1 cancer incidence in the UK.’ British Journal of Cancer, 95(2) p. 233.

Wallace, M. D., Pfefferle, A. D., Shen, L., McNairn, A. J., Cerami, E. G., Fallon, B. L., Rinaldi, V. D., Southard, T. L., et al. (2012) ‘Comparative oncogenomics implicates the neurofibromin 1 gene (NF1) as a breast cancer driver.’ Genetics (Austin), 192(2) pp. 385-396.